Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans.
Prostaglandin E2 (PGE2), thromboxane B2 (TXB2), and salicylic acid were measured in blood samples from 10 healthy men after administration of antiinflammatory doses of aspirin (3.9 g/day) or salsalate (3.0 g/day). Each medication was given for 3 days, followed by an observation period of 13 days. Plasma salicylate concentrations were slightly, but generally insignificantly, higher during aspirin dosing, although both drugs produced salicylic acid levels in the antiinflammatory range. Serum levels of PGE2 and TXB2, which reflected synthesis of cyclo-oxygenase products by platelets, were minimally affected by salsalate but profoundly suppressed by aspirin. When medication was discontinued, the effects of salsalate on serum PGE2 and TXB2 were readily reversible within 36 h, whereas the recovery from aspirin was still incomplete after 13 days of observation. These results indicate that the two orally administered salicylates have differential effects on prostaglandin synthesis in platelets and may also differ in their therapeutic and adverse effects.
D000328:Adult; D001241:Aspirin / Q000097:blood / Q000494:pharmacology*; D015232:Dinoprostone; D006801:Humans; D008297:Male; D011458:Prostaglandins E / Q000097:blood*; D012459:Salicylates / Q000097:blood / Q000494:pharmacology*; D013929:Thromboxane B2 / Q000097:blood
D011458:Prostaglandins E; D012459:Salicylates; D013929:Thromboxane B2; D015232:Dinoprostone; D001241:Aspirin; C014182:salicylsalicylic acid